Methods for biomolecule and biomolecule complex (bmc) detection and analysis and the use of such for research and medical diagnosis (US)

So far research has been focused almost exclusively on searching individual proteins as protein biomarkers for cancer detection and diagnosis. The level change of an individual protein target in biological systems and fluids is most commonly studied to identify their potential association with cancer. Using a nanoparticle aggregation immunoassay, we discovered several proteins that are substantially more complexed/aggregated in different cancer than normal tissue. The level of protein complex/aggregate in a biological system can serve as a biomarker for disease detection and as a target of therapy. In one particular example, prostate cancer is clearly distinguishable from normal prostate and prostate with benign conditions according to the complex/aggregate level of a unique biomarker protein

LASER PROCESSING OF METAL NANOPARTICLE / POLYMER COMPOSITES

A method of forming articles having closed microchannels includes the steps of providing a substrae including a composite material, the composite having metal nanoparticles dispersed in a polymer matrix. The substrate is irradiated with a laser beam at an intensity and time sufficient to selectively remove the polymer below a surface of said substrate to form at least one microchannel, wherein the intensity and time is low enough to avoid removing the polymer above the microchannel, wherein an article having at least one closed microchannel is formed. A metal nanoparticle/polyer composite composition can have functionality that can undergo addition reactions to seal or join pieces of polymers or composites upon irradiation of the composition placed on one or more pieces

Dispersions of Carbon Nanotubes in Copolymer Solutions and Functional Composite Materials and Coatings Therefrom

A dispersion includes non-chemically modified carbon nanotubes, a soluble block coploymer providing at least one block of a conjugated polymer, and at least one solvent. at 25 degrees C, exclusive of any mechanical force and after one hour, at least 90% of the carbon nanotubes exist in the dispersion as isolated nanotubes. The compenents of the dispersin can be combined with a polymer miscible with the block copolymer to form a carbon nanotube polymer composite upon removal of the solvent. The dispersion can be cast on a substrate and then dried to form a coating, including forming a superhydrophobic coating on the substrate. The non-conjugated polymer of the block copolymer or another miscible conjugated polymer including a copolymer can include functionalities that non-covalently attach to the carbon nanotube surface, such as for enhanced solubility or enhanced biocompatibility

Detection of analytes using metal nanoparticle probes and dynamic light scattering (US)

Disclosed herein are systems and methods for detecting Chemical Species, Biomolecules and Biotargets (Analytes) using receptor functionalized metal nanoparticles and Dynamic Light Scattering

Predicting Prostate Cancer Aggressiveness through a Nanoparticle Test

Prostate cancer (PCa) is the most common malignancy and the second leading cause of cancer death in American men. Due to the lack of accurate tests to distinguish aggressive cancer from indolent tumor, prostate cancer is often over-treated. Post-surgery pathology analysis revealed that 30% of tumors removed by radical prostatectomy are deemed clinically insignificant and would not have required such invasive treatment.^1^ Over-diagnosis and treatment of low-risk prostate cancer has serious and long-lasting side effect: as high as 70% of the patients who receive radical prostatectomy treatment will suffer a loss of sexual potency that cannot be remedied by drugs such as sildenafil citrate.^2^ We herein report a simple nanoparticle-serum protein adsorption test that not only can distinguish prostate cancer from normal and benign conditions, but also is capable of predicting the aggressiveness of prostate cancer quantitatively. This new test could potentially deliver the long-expected and very much needed solution for better individualization of prostate cancer treatment

LASER IRRADIATION OF METAL NANOPARTICLE/POLYMER COMPOSITE MATERIALS FOR CHEMICAL AND PHYSICAL TRANSFORMATIONS

A metal nanoparticle supported on or dispersed in a polymer is irradiated with photons from a laser source to address the nanoparticles. The polymer is transmissive to the photons and addressed nanoparticles transform the energy of the photon to heat which is transferred to a material in the vicinity of the nanoparticle. The locally heated material undergoes a physical or chemical transformation upon heating. The transformed material can be a material in the proximity of the metal nanoparticle supported polymer or metal nanoparticle/polymer composite. In this manner thermally induced physical or chemical transformations can be carried out in very small volumes of material without significant heating to the bulk of the materia

Polymer Composites Having Highly Dispersed Carbon Nanotubes and Methods for Forming Same

A method of forming carbon nanotube-polymer composites includes the steps of forming a mixture solution including a plurality of carbon nanotubes dispersed in a co-solvent. The co-solvent includes an organic solvent and a second solvent being a short chain fluorinated carboxylic acid having a boiling point below 150 degrees C which is less oxidizing than nitric acid, and is soluble in both the organic solvent and water. The first polymer is mixed with the mixture solution to form a polymer including mixture. The co-solvent is removed from the polymer mixture to form a dispersed nanotube-polymer composite. The second solvent can be trifluoroacetic acid

Polymer Composites Having Highly Dispersed Carbon Nanotubes

A carbon nanotube-polymer composite includes a polymer continuous phase having at least a first polymer and a plurality of carbon nanotubes dispersed in the polymer continuous phase. The carbon nanotubes are non-functionalized nanotubes. The carbon nanotubes are between 0.05 and 40 weight % of the composite. At least 98% of the carbon nanotubes are not involved in nanotube bundles

A Functional Nuclear Epidermal Growth Factor Receptor, Src and Stat3 Heteromeric Complex in Pancreatic Cancer Cells

Evidence is presented for the nuclear presence of a functional heteromeric complex of epidermal growth factor (EGFR), Src and the Signal Transducer and Activator of Transcription (Stat)3 proteins in pancreatic cancer cells. Stat3 remains nuclear and associated with Src or EGFR, respectively, upon the siRNA knockdown of EGFR or Src, demonstrating the resistance of the complex to the modulation of EGFR or Src alone. Significantly, chromatin immunoprecipitation (ChIP) analyses reveal the nuclear EGFR, Src and Stat3 complex is bound to the c-Myc promoter. The siRNA knockdown of EGFR or Src, or the pharmacological inhibition of Stat3 activity only marginally suppressed c-Myc expression. By contrast, the concurrent modulation of Stat3 and EGFR, or Stat3 and Src, or EGFR and Src strongly suppressed c-Myc expression, demonstrating that the novel nuclear heteromeric complex intricately regulates the c-Myc gene. The prevalence of the transcriptionally functional EGFR, Src, and Stat3 nuclear complex provides an additional and novel mechanism for supporting the pancreatic cancer phenotype and explains in part the insensitivity of pancreatic cancer cells to the inhibition of EGFR, Src or Stat3 alone

Developing a nanoparticle test for prostate cancer scoring

<p>Abstract</p> <p>Background</p> <p>Over-diagnosis and treatment of prostate cancer has been a major problem in prostate cancer care and management. Currently the most relevant prognostic factor to predict a patient's risk of death due to prostate cancer is the Gleason score of the biopsied tissue samples. However, pathological analysis is subjective, and the Gleason score is only a qualitative estimate of the cancer malignancy. Molecular biomarkers and diagnostic tests that can accurately predict prostate tumor aggressiveness are rather limited.</p> <p>Method</p> <p>We report here for the first time the development of a nanoparticle test that not only can distinguish prostate cancer from normal and benign conditions, but also has the potential to predict the aggressiveness of prostate cancer quantitatively. To conduct the test, a prostate tissue lysate sample is spiked into a blood serum or human IgG solution and the spiked sample is incubated with a citrate-protected gold nanoparticle solution. IgG is known to adsorb to citrate-protected gold nanoparticles to form a "protein corona" on the nanoparticle surface. From this study, we discovered that certain tumor-specific molecules can interact with IgG and change the adsorption behavior of IgG to the gold nanoparticles. This change is reflected in the nanoparticle size of the assay solution and detected by a dynamic light scattering technique. Assay data were analyzed by one-way ANOVA for multiple variant analysis, and using the Student <it>t-</it>test or nonparametric Mann-Whitney <it>U-</it>tests for pairwise analyses.</p> <p>Results</p> <p>An inverse, quantitative correlation of the average nanoparticle size of the assay solution with tumor status and histological diagnostic grading was observed from the nanoparticle test. IgG solutions spiked with prostate tumor tissue exhibit significantly smaller nanoparticle size than the solutions spiked with normal and benign tissues. The higher grade the tumor is, the smaller the nanoparticle size is. The test particularly revealed large differences among the intermediate Grade 2 tumors, and suggested the need to treat them differently.</p> <p>Conclusion</p> <p>Development of a new nanoparticle test may provide a quantitative measure of the prostate cancer aggressiveness. If validated in a larger study of patients with prostate cancer, this test could become a new diagnostic tool in conjunction with Gleason Score pathology diagnostics to better distinguish aggressive cancer from indolent tumor.</p